ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 59 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,096,113 | -13.4% | 522,992 | +8.6% | 0.00% | – |
| Q2 2023 | $3,574,236 | +293.9% | 481,703 | +401.7% | 0.00% | – |
| Q1 2023 | $907,342 | -51.8% | 96,015 | -45.6% | 0.00% | – |
| Q4 2022 | $1,881,110 | +238.9% | 176,630 | +134.8% | 0.00% | – |
| Q3 2022 | $555,000 | +53.3% | 75,215 | 0.0% | 0.00% | – |
| Q2 2022 | $362,000 | +12.4% | 75,215 | +19.4% | 0.00% | – |
| Q1 2022 | $322,000 | -4.5% | 63,015 | +12.5% | 0.00% | – |
| Q4 2021 | $337,000 | -31.2% | 55,992 | +1.3% | 0.00% | – |
| Q3 2021 | $490,000 | +12.1% | 55,292 | 0.0% | 0.00% | – |
| Q2 2021 | $437,000 | – | 55,292 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 37,500 | $225,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 73,366 | $441,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 56,673 | $341,000 | 0.04% |
| GOODWIN DANIEL L | 10,000 | $60,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 88,966 | $535,000 | 0.01% |
| EMFO, LLC | 1,666 | $10,000 | 0.01% |
| Virtu Financial LLC | 14,020 | $84,000 | 0.01% |
| Retirement Group, LLC | 1,129 | $17,000 | 0.01% |
| BLAIR WILLIAM & CO/IL | 86,866 | $522,000 | 0.00% |
| Hartford Financial Management Inc. | 598 | $4,000 | 0.00% |